Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.

MLA

Kulu, Yakup, et al. “Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.” Annals of Surgical Oncology, vol. 23, no. 1, Jan. 2016, pp. 106–13. EBSCOhost, https://doi.org/10.1245/s10434-015-4832-5.

APA

Kulu, Y., Tarantino, I., Billeter, A. T., Diener, M. K., Schmidt, T., Büchler, M. W., & Ulrich, A. (2016). Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer. Annals of Surgical Oncology, 23(1), 106–113. https://doi.org/10.1245/s10434-015-4832-5

Chicago

Kulu, Yakup, Ignazio Tarantino, Adrian T Billeter, Markus K Diener, Thomas Schmidt, Markus W Büchler, and Alexis Ulrich. 2016. “Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.” Annals of Surgical Oncology 23 (1): 106–13. doi:10.1245/s10434-015-4832-5.